Basic Information
BeneFIX Powder and Solvent for Solution for Injection 250iu/vial
INJECTION, POWDER, FOR SOLUTION
Regulatory Information
SIN13803P
May 20, 2010
Prescription Only
Therapeutic
INTRAVENOUS
August 10, 2023
May 30, 2025
XB02BD04
Company Information
PFIZER PRIVATE LIMITED
PFIZER PRIVATE LIMITED
Active Ingredients
Nonacog Alfa
Strength: 250IU/vial (69IU/mL)
Detailed Information
Contraindications
**4.3 Contraindications** BeneFIX may be contraindicated in patients with a known history of hypersensitivity to any of the constituents of the preparation or in patients with a known history of hypersensitivity to hamster proteins.
Indication Information
**4.1 Therapeutic indication** Treatment and prophylaxis of bleeding in patients with hemophilia B (congenital factor IX deficiency).